Alzai Health Corp. has seen significant price movement recently, with a notable decline over the past week.
This week, Alzai Health Corp. (ALZI.V) experienced a decline of nearly 19%, continuing a downward trend that has persisted throughout the year. As of the last close, the stock is trading at C$0.31, reflecting a year-to-date drop of 33.33%. Let's delve into the details surrounding this performance.
Investor takeaway: Investors should be cautious given the significant decline in Alzai Health's stock price and the lack of recent company news to provide a catalyst for recovery.
Advertisement
Alzai Health Corp.
ALZI.V
ALZI.V
Alzai Health Corp.
WealthAwesomeMarket cap
$19.44M
52W high
$0.50
52W low
$0.28
1W change
-18.92%
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ALZI's historical volatility
30-Day Vol
124.2%
Annualized
90-Day Vol
112.1%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.25
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.28 | C$0.18 – C$0.43 |
| 60 trading days | C$0.27 | C$0.15 – C$0.49 |
| 90 trading days | C$0.25 | C$0.12 – C$0.53 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Stock Performance Overview
Alzai Health Corp. has seen its stock price decline by 18.92% over the past week, highlighting ongoing challenges.
Bull case
A potential turnaround could happen if the company announces new developments or partnerships that boost investor confidence and improve market sentiment.
Bear case
The ongoing decline in share price, along with a lack of profitability and negative earnings per share, raises concerns about the company's financial health and future performance.
Recent Price Action
Alzai Health Corp. has faced a challenging week, with its stock price closing at C$0.31, reflecting a drop of 18.92% over the past week. This decline continues a trend that has seen the stock decrease by 33.33% year-to-date.
Technical Picture
Advertisement
Currently, Alzai Health's stock is trading below both its 50-day moving average of C$0.36 and its 200-day moving average of C$0.40, indicating a bearish trend. The stock has a 52-week range of C$0.28 to C$0.50, with the current price at approximately 16% of that range. Recent trading volume has been relatively low, with 40,000 shares exchanged, which is about 0.37 times the 20-day average volume of 54,543 shares.
Financial Overview
Alzai Health Corp. has a market capitalization of approximately C$19.4 million. The company has not reported any profit margin or return on equity, with an earnings per share (EPS) of -C$0.07, indicating ongoing financial challenges. Investors may want to consider these metrics when evaluating their positions in the stock.
Insider Activity
No recent insider activity has been reported for Alzai Health Corp., suggesting a stable insider sentiment at this time.
Price Action Summary
As of the last close, Alzai Health Corp. stock is priced at C$0.31, unchanged from the previous day, but down significantly over the past week.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
